Page 63 - Use Authorization News Today

Author Bio Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights What happened Shares of Novavax (NASDAQ:NVAX) were sinking 12.5% lower as of 3:32 p.m. EST on Monday. The biotech announced that it has completed enrollment of a late-stage st...

SunStar + February 22, 2021 FOR two consecutive weeks, Muntinlupa City held virtual town hall meetings to drum up high participation in its forthcoming Covid vaccination program. Invited to the separate meetings with the theme "Bakunado, Protektado" were representatives of homeowners groups, religious groups, civic groups, Sangguniang Kabataan, the Gender Development Office and the City Administrators Office. During the first meeting held February 10, the resource speakers were Inf...

Manipur Anganwadi worker dies a week after taking COVID-19 vaccine A 48-year-old Anganwadi worker in Manipur has died a week after receiving her first dose of COVID-19 vaccine, officials said on Saturday. W. Sundari Devi of Kumbi Terakha area in Bishunpur district had received her first shot of the COVID-19 vaccine on February 12 at Kumbhi primary health centre (PHC), they said. She was taken to the Moirang community health centre (CHC) on February 18 as she had breathing problems and died at t...

German Proposed U.S. EUA label update would enable the vaccine to be stored at -25°C to -15°C (-13°F to 5°F) for a total of two weeks If approved, new storage option could offer pharmacies and vaccination centers greater flexibility in managing and maintaining vaccine distribution and supply NEW YORK and MAINZ, GERMANY, February 19, 2021 (GLOBE NEWSWIRE) — BioNTech SE (Nasdaq: BNTX) today announced the submission of new data to the U.S. Food and Drug Administration (FDA) demonstrating t...

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced the submission of new data to the U.S. Food and Drug Administration (FDA)...

Pfizer's COVID-19 vaccine is more stable than originally believed, the pharmaceutical company has said today, submitting new evidence for cold temperature

Proposed U.S. EUA label update would enable the vaccine to be stored at -25°C to -15°C (-13°F to 5°F) for a total of two weeks If approved, new storage...

Pfizer says deep-freeze storage unnecessary as Israeli study shows vaccine 85% effective after 1st shot February 19, 2021 / 8:00 AM / CBS/AFP Inside Israels COVID-19 vaccination campaign Jerusalem — The first dose of the Pfizer vaccination is 85% effective against coronavirus infection between two and four weeks after inoculation, according to a study published in the Lancet medical journal. The pharmaceutical giant and its German partner BioNTech, meanwhile, have told the U.S. Food ...

NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE) and BioNTech SE (BNTX) said that they have submitted new data to the U.S. Food and Drug Administration demonstrating the stability of their COVID-19

‘As an alternative or complement to storage in an ultra-low temperature freezer’.